TransMedics Group Inc

TMDX

Company Profile

  • Business description

    TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

  • Contact

    200 Minuteman Road
    AndoverMA01810
    USA

    T: +1 978 552-0900

    https://www.transmedics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    728

Stocks News & Analysis

stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.
stocks

Undervalued ASX share searches for cost savings

Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks

Chart of the Week: Where we see opportunities after year end market sell-off

The latest insights from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,983.3028.900.32%
CAC 408,068.6217.14-0.21%
DAX 4024,186.49108.12-0.45%
Dow JONES (US)48,458.05245.96-0.51%
FTSE 1009,649.0354.13-0.56%
HKSE25,976.79446.281.75%
NASDAQ23,195.17398.69-1.69%
Nikkei 22550,836.55687.731.37%
NZX 50 Index13,406.9111.040.08%
S&P 5006,827.4173.59-1.07%
S&P/ASX 2008,697.3032.400.37%
SSE Composite Index3,889.3516.030.41%

Market Movers